Insider Selling: ICU Medical, Inc. (NASDAQ:ICUI) CEO Sells 1,373 Shares of Stock

ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) CEO Vivek Jain sold 1,373 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the transaction, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at approximately $16,262,119.64. The trade was a 1.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

Vivek Jain also recently made the following trade(s):

• On Monday, December 2nd, Vivek Jain sold 12,000 shares of ICU Medical stock. The shares were sold at an average price of $162.91, for a total transaction of $1,954,920.00.
• On Friday, November 1st, Vivek Jain sold 12,000 shares of ICU Medical stock. The stock was sold at an average price of $171.84, for a total transaction of $2,062,080.00.

ICU Medical Price Performance

Shares of ICU Medical stock traded up $2.81 during midday trading on Thursday, reaching $157.98. The company had a trading volume of 208,164 shares, compared to its average volume of 269,089. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The stock has a fifty day simple moving average of $164.56 and a 200 day simple moving average of $155.51. ICU Medical, Inc. has a 1-year low of $86.80 and a 1-year high of $196.26. The company has a market capitalization of $3.87 billion, a price-to-earnings ratio of -34.57 and a beta of 0.62.

Institutional Investors Weigh In On ICU Medical

Hedge funds and other institutional investors have recently made changes to their positions in the company. Victory Capital Management Inc. boosted its holdings in ICU Medical by 2,966.3% in the second quarter. Victory Capital Management Inc. now owns 141,848 shares of the medical instruments supplier's stock valued at $16,844,000 after acquiring an additional 137,222 shares during the last quarter. Millennium Management LLC lifted its position in ICU Medical by 327.8% during the 2nd quarter. Millennium Management LLC now owns 136,070 shares of the medical instruments supplier's stock valued at $16,158,000 after purchasing an additional 104,264 shares during the period. FMR LLC boosted its stake in shares of ICU Medical by 2,676.6% in the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier's stock valued at $18,968,000 after purchasing an additional 100,345 shares during the last quarter. Granite Investment Partners LLC acquired a new stake in shares of ICU Medical during the 2nd quarter worth approximately $10,650,000. Finally, State Street Corp raised its stake in shares of ICU Medical by 9.3% during the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock worth $165,384,000 after buying an additional 77,506 shares during the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have commented on ICUI. Jefferies Financial Group upgraded shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target on the stock in a research report on Wednesday, December 11th. Raymond James boosted their target price on ICU Medical from $158.00 to $190.00 and gave the stock an "outperform" rating in a report on Thursday, September 12th. StockNews.com raised ICU Medical from a "hold" rating to a "buy" rating in a report on Wednesday, November 20th. KeyCorp boosted their price objective on ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 13th. Finally, Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research note on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, ICU Medical currently has an average rating of "Moderate Buy" and an average target price of $199.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.